Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
02/2009
02/05/2009WO2009016218A2 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives
02/05/2009WO2008150486A3 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
02/05/2009WO2008124703A3 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
02/05/2009WO2008104203A3 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers
02/05/2009US20090036676 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
02/05/2009US20090036673 Ecteinascidin 743; 5-(1,2-diaminoethyl-), 3,4-methylenedioxyphenol intermediate, of which the amine group cyclizes
02/05/2009US20090036492 Novel Cercosporamide Derivative
02/05/2009US20090036466 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
02/05/2009US20090036457 Utilities of olefin derivatives
02/05/2009US20090036448 Pyrimidine derivatives and methods of treatment related to the use thereof
02/05/2009US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists
02/05/2009US20090036439 5-[(3',5'-dichloro-1,1'-biphenyl-3-yl)methylene]-3-(3,5-dichlorophenyl)-4-hydroxyfuran-2(5H)-one; bacterial cell wall biosynthesis via the Mur enzyme pathway; bactericides; paraciticides; nematocides; antibiotic-resistant diseases; agiculture; veterinary medicine
02/05/2009US20090036438 Five-membered heterocycles useful as serine protease inhibitors
02/05/2009US20090036434 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
02/05/2009US20090036420 Benzamide derivatives and their use for treating cns disorders
02/05/2009US20090035309 Substituted Benzazoles and Methods of Their Use as Inhibitors of RAF Kinase
02/05/2009US20090035306 Quinazolinone modulators of tgr5
02/05/2009US20090032782 Photochromic materials having extended pi-conjugated systems and compositions and articles including the same
02/05/2009CA2695304A1 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
02/05/2009CA2695076A1 Process for the preparation of alfuzosin hydrochloride
02/05/2009CA2693817A1 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
02/04/2009EP2020407A1 2-oxetanone derivative and process for production thereof
02/04/2009EP2020404A1 Cyanomethyl substituted N-Acyl Tryptamines
02/04/2009EP2020402A1 Dehydroxylated fluorinating agent
02/04/2009EP2019827A1 Integrase inhibitors 3
02/04/2009EP2019825A1 Inhibitors of human immunodeficiency virus replication
02/04/2009EP2019820A1 Therapeutic pyrrolidine compounds
02/04/2009EP2019674A2 Histone deacetylase and tubulin deacetylase inhibitors
02/04/2009EP1601653B1 Process for the production of substituted nicotinic acid esters
02/04/2009CN101360742A Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
02/04/2009CN101360741A Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators
02/04/2009CN101360737A 2-amino-5-piperidinylimidazolone compounds and use thereof for (insert beta symbol)-secretase modulation
02/04/2009CN101360711A L-phenylalanine derivatives and its application as integrin antagonists
02/04/2009CN100457757C Novel spiro compounds
02/04/2009CN100457752C Pyridine derivatives useful for inhibiting sodium/calcium exchange system
02/04/2009CN100457730C Indoles having anti-diabetic activity
02/04/2009CN100457728C Tyrosine kinase inhibitors
02/04/2009CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes
02/04/2009CN100457118C 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
02/03/2009US7485727 4-Phenoxy-, 4-phenylthio-, 4-phenylsulfonyl- or 5-phenylsulfinyl-1-(2-pyridinyl)piperidine derivatives; insecticides, miticides and nematocides
02/03/2009US7485724 2,4-pyrimidinediamine compounds and their uses
02/03/2009US7485653 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
02/03/2009US7485647 2-aminoquinoline derivatives
02/03/2009US7485644 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation
02/03/2009US7485641 Substituted 3-amino-pyrrolidino-4-lactams
02/03/2009US7485638 Pyrimidine compounds
02/03/2009US7485427 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, and nucleic acids); Exposure of the conjugate to radiation releases the target in a functional form and completely unaltered
02/03/2009CA2478146C Spiro and dispiro 1,2,4-trioxolane antimalarials
02/03/2009CA2425164C (4-acylaminopiperidin-1-yl)acetamides as neurokinin antagonists
02/03/2009CA2352786C Benzofuran derivatives, process for the preparation of the same and uses thereof
02/03/2009CA2259936C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
01/2009
01/29/2009WO2009015254A1 Triazine kinase inhibitors
01/29/2009WO2009014217A1 Bicyclic pyrrole derivative
01/29/2009WO2009014150A1 Benzimidazole derivative
01/29/2009WO2009014100A1 p27 PROTEIN INDUCER
01/29/2009WO2009013390A1 2, 3-dihydrobenzo[1, 4] dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases
01/29/2009WO2009013348A2 Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
01/29/2009WO2009013333A1 Alkylacetylene substituted acyltryptophanols
01/29/2009WO2009012656A1 Inhibitors for matrix metalloproteinases, pharmaceutical compositions containing them and their uses
01/29/2009WO2008152159A3 6 -acyloxy- 7-meth0xy- 2, 2 -dimethylchromane compounds and their use as pigmentation-regulators
01/29/2009WO2008118379A3 AMINO-5-[4-(DIFLUOROMETHOXY)PHENYL]-5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
01/29/2009US20090030202 Material for organic electroluminescent element and organic electroluminescent element employing the same
01/29/2009US20090030041 N-substituted N-(4-piperidinyl) Amide Derivative
01/29/2009US20090030038 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor
01/29/2009US20090030032 Bicyclic Compound, Production and Use Thereof
01/29/2009US20090030023 Pyrimidine compounds and medicinal composition thereof
01/29/2009US20090030021 Quinazoline Derivatives and Therapeutic Use Thereof
01/29/2009US20090030008 Piperazine derivatives and their use as therapeutic agents
01/29/2009US20090029996 Pyridazin-3(2H)-One Derivatives And Their Use As Pde4 Inhibitors
01/29/2009US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
01/29/2009US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors
01/29/2009US20090029987 Pharmaceutical Compositions for the Prevention and Treatment of Complex Diseases and Their Delivery by Insertable Medical Devices
01/29/2009US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
01/29/2009US20090029979 5-htx modulators
01/29/2009DE102007035323A1 New diazen-1-ium-1,2-diolate substituted ketoconazole derivatives are ergosterol biosynthesis inhibitors useful as an active agent against microbial pathogenic germs, e.g. fungus, and an antiinflammatory active agent
01/29/2009CA2697166A1 Isophthalamide derivatives inhibiting betasecretase activity
01/29/2009CA2694275A1 Organic compounds
01/29/2009CA2694216A1 Benzimidazole derivative
01/29/2009CA2693804A1 2,3-dihydrobenzo[1,4] dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases
01/29/2009CA2693377A1 5-pyridinone substituted indazoles
01/28/2009EP2019102A1 Alkylacetylene substituted Acyltryptophanols
01/28/2009EP2019093A1 Urea type cinnamide derivative
01/28/2009EP2019090A1 Substituted beta-phenyl-alpha-hydroxy propanoic acid, synthesis method and use thereof
01/28/2009EP2018378A2 Heterocyclic inhibitors of 11-b hydroxyl steroid dehydrogenase type i and methods of using the same
01/28/2009EP2018371A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
01/28/2009EP2018370A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors
01/28/2009EP1177181B1 Substituted bicyclic compounds
01/28/2009EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
01/28/2009CN101356170A Heterocyclic modulators of ATP-binding cassette transporters
01/28/2009CN101356159A Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2H)-isoquinolones and methods of use thereof
01/28/2009CN101353344A Pyrazolyl-substituted heterocycles and their use as phytosanitary products
01/28/2009CN101353341A Colorant reacted by oxyalkylene-substituted aminophenol intermediate
01/28/2009CN100455579C Compounds and compositions as protein kinase inhibitors
01/28/2009CN100455570C Quinolinone / benzoxazinone derivatives and uses thereof
01/28/2009CN100455568C 6-position substituted indoline, production and use thereof as medicament
01/27/2009US7482478 High trans-selectivities (up to >98%) and good yields (up to 99%)
01/27/2009US7482473 Coumarin derivative
01/27/2009US7482471 catalytic reaction of 4-(oxiranylmethoxy)carbazole with N-2-[2-(methoxy)phenoxy]ethyl]benzylamine in aprotic solvent; debenzylation of N-benzyl carvidilol to form carvidilol; less Pd catalyst needed; byproduct inhibition; high yield, industrial scale, racemic or enantiomeric forms
01/27/2009US7482466 Hydroxamates as therapeutic agents
01/27/2009US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma